China Apixaban Market Report 2021: Analysis of Major Manufacturers 2016-2020, Prices 2020-2021 & Prospects 2021-2025
04 mai 2021 04h28 HE
|
Research and Markets
Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Apixaban Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales revenue of Apixaban...
Global Anemia and Other Blood Disorder Drugs Markets 2020-2030: Focus on Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
25 mars 2021 05h18 HE
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
29 déc. 2020 17h20 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...
Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19
29 déc. 2020 17h04 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific...
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
15 déc. 2020 08h30 HE
|
ARCA biopharma, Inc.
rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients, including after availability of vaccinesrNAPc2 is the only novel compound being developed for COVID-19...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market Report 2020: Increasing Awareness Regarding Available Treatment Alternatives to Drive Market Growth
01 déc. 2020 05h18 HE
|
Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been...
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
23 nov. 2020 08h30 HE
|
ARCA biopharma, Inc.
Development addresses need for treatments for patients hospitalized with COVID-19 whether vaccines are available or notAB201 is the only novel compound being developed for COVID Associated...
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
02 nov. 2020 08h30 HE
|
ARCA biopharma, Inc.
Initiation of Phase 2b clinical trial evaluating AB201 as a potential treatment for COVID19 anticipated in fourth quarterTopline data from trial anticipated Q2 2021 WESTMINSTER, Colo., Nov. 02,...
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
07 oct. 2020 08h30 HE
|
ARCA biopharma, Inc.
Initiation of Phase 2b clinical trial anticipated in Q4 2020Trial to enroll approximately 100 patients hospitalized with COVID-19Topline data anticipated Q2 2021 WESTMINSTER, Colo., Oct. 07, 2020 ...
Global and United States Anticoagulants Market Size & Forecast Report 2020-2024 with Impact Analysis of COVID-19
14 sept. 2020 07h38 HE
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to...